On December 11, a quiet force in American healthcare reform will step into the spotlight on the lawn of the U.S. Capitol. Dr. Marion Mass, a pediatrician and longtime advocate for cost transparency, will stand alongside independent pharmacists and patients as the Pharmacists Fight Back Act is introduced, a bipartisan bill designed to confront the big pharmacy benefit managers who have helped drive drug prices into the stratosphere. Though the coalition is broad, Dr. Mass is one of its clearest and most unflinching voices, calling attention to the way PBMs extract money from the system while obstructing care and burdening both clinicians and patients.
Her journey to this moment began years earlier. “I decided in 2017 that cost was the central issue plaguing our healthcare system,” she explained. “So I followed the money. The biggest pharmacy benefit managers seemed like the lowest hanging fruit: they make more money than the pharmaceutical companies themselves and yet create no product, do no research (heck, they don’t even move the product around the country).” What struck her most was not just the sheer scale of PBM profits, but the way those profits translated into practical barriers for physicians. Formularies controlled by middlemen, she says, have made it harder to get patients the medications they truly need, while ever-rising drug costs place unbearable strain on employers, independent practices, and the very patients those systems claim to serve.
Healthcare is full of fine print, power plays, and rules physicians are expected to navigate without a map. This expert-led SoMeDocs resource covers contract review, PBMs, healthcare law, patient-physician relationships, and the issues shaping medical practice today.
While Dr. Mass is a clinician, she has become something more than that in the policy arena: a translator who can make the mechanics of healthcare economics accessible to the public, and a conscience reminding lawmakers that the system’s failures have human consequences. Her work has caught the attention of many, including figures outside medicine. One of the most outspoken and action oriented has been entrepreneur Mark Cuban, whose Cost Plus Drug Company has exposed how dramatically PBMs can inflate medication prices. Cuban’s efforts underscore the very problems Dr. Mass has been warning about for years, and while he comes from the world of business rather than medicine, his calls for transparency have amplified the urgency of the reform she champions.
Still, this gathering in Washington is not about celebrity involvement. It is about elevating the clinicians who have been living inside this broken system. Dr. Mass has spent years listening to independent pharmacists describe how PBM practices undermine their survival, from unfair reimbursement to steering patients toward PBM-affiliated pharmacies. She has also heard from physicians whose patients face delays or denials because formularies are built around profit incentives rather than clinical need. The two groups, she argues, are natural allies: independent, community-based, and increasingly marginalized by corporate systems that reward administrative intermediaries more than patient care.
Bring the idea. We’ll help build the show. From planning and production to polish and launch, we turn expertise into content that looks professional, feels intentional, & gives your audience a reason to return.
The Pharmacists Fight Back Act seeks to reverse some of the most damaging PBM behaviors. Dr. Mass hopes the bill will ensure that the “kickback money”, the rebates PBMs negotiate, finally reaches the people actually paying for their medications. She also wants to see independent pharmacies receive fair reimbursement so communities no longer lose local pharmacies to closures. And just as importantly, she believes physicians must regain the authority to determine which medications patients receive. “Boot the suits, put the scrubs back in charge,” she says, capturing both her incredulity and her vision for a better system.
Across the country, PBM influence has grown quietly but profoundly. Employers have watched drug and insurance costs rise each year with little transparency. Patients face unpredictable copays and restricted access. Independent pharmacies, especially in rural and underserved areas, are shutting down in alarming numbers. Pennsylvania alone saw more than 200 closures following a reform law that advocates say didn’t go far enough to rein in PBM power. As those pharmacies disappear, communities lose not just a place to collect medications, but a trusted source of frontline care.
Find your next favorite healthcare show. Browse our series section for bold voices, real stories, and expert-led conversations worth pressing play for.
Physicians feel the pressure in different but parallel ways. An independent doctor running a practice is responsible not only for diagnosing illnesses, but also for providing health benefits to staff. As premiums soar, practices struggle to offer competitive wages or maintain the team members who make clinical care possible. Many physicians don’t realize how much of this pain traces back to PBM contracts negotiated far outside their view, yet directly impacting their budgets and their patients’ access to treatments.
That is why Dr. Mass’s presence at the Capitol is meaningful. She is not merely attending a political event; she is representing the clinicians on the ground who have been asking for transparency, sustainability, and sanity in the drug supply chain. Her voice bridges professional silos and political divides, speaking for physicians, pharmacists, and patients who see the same problems from different angles. The bipartisan support for the Pharmacists Fight Back Act suggests the moment is ripe for change, but legislation alone will not fix a system decades in the making. What can shift the conversation is leadership – credible, informed, relentless leadership – and Dr. Mass has become one of its most recognizable champions.
As she prepares to stand before the Capitol, her message is simple: this fight is not abstract. It affects every prescription written, every patient counseled, every business decision made by an independent practice or pharmacy. Reform is not optional; it is overdue. And while policy debates play out in Washington, the people in scrubs are the ones who understand what is at stake.
I decided in 2017 that cost was the central issue plaguing our healthcare system. So I followed the money.
